OOIR: Observatory of International Research

Papers

(The H4-Index of Schizophrenia Research is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research	252
COVID-19, mobile health and serious mental illness	90
Language as a biomarker for psychosis: A natural language processing approach	81
Sleep and schizophrenia: From epiphenomenon to treatable causal target	71
COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?	61
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development	61
The impact of COVID-19 on individuals living with serious mental illness	58
The role of the gut microbiome in the development of schizophrenia	56
Schizophrenia and the retina: Towards a 2020 perspective	48
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms	48
Thalamus-related anomalies as candidate mechanism-based biomarkers for psychosis	45
Genome-wide association studies in schizophrenia: Recent advances, challenges and future perspective	45
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk	44
Cognitive biases in individuals with psychotic-like experiences: A systematic review and a meta-analysis	41
Changes of psychotic-like experiences and their association with anxiety/depression among young adolescents before COVID-19 and after the lockdown in China	40
A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia	40
Relationships between psychiatric symptoms, functioning and personal recovery in psychosis	40
A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis	40
Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis	39
Gut microbiome in serious mental illnesses: A systematic review and critical evaluation	38
The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders – A systematic review of magnetic resonance spectroscopy studies	37
Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population	36
Lower speech connectedness linked to incidence of psychosis in people at clinical high risk	35
Everything is connected: Inference and attractors in delusions	34
Neurodegenerative model of schizophrenia: Growing evidence to support a revisit	34

North American Prodrome Longitudinal Study (NAPLS 3): Methods and baseline description	33
Going deep into schizophrenia with artificial intelligence	33
Ambulatory digital phenotyping of blunted affect and alogia using objective facial and vocal analysis: Proof of concept	33
Evidence for altered energy metabolism, increased lactate, and decreased pH in schizophrenia brain: A focused review and meta-analysis of human postmortem and magnetic resonance spectroscopy studies	32
Targeting cognition in schizophrenia through transcranial direct current stimulation: A systematic review and perspective	32
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features	31